Boulder, CO, United States of America

Daniel Held

USPTO Granted Patents = 12 


Average Co-Inventor Count = 2.1

ph-index = 3

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: **The Innovative Mind of Daniel Held in Boulder, CO**

Introduction

Daniel Held is a remarkable inventor based in Boulder, Colorado, who has made significant contributions to the field of biotechnology. With an impressive portfolio of 12 patents, his work focuses on enhancing production processes and genetic editing technologies.

Latest Patents

Among his latest patents, Daniel has pioneered methods for creating rationally-designed mutations in the thrA gene, aimed at boosting lysine production. This invention has promising applications in the production of supplements and nutraceuticals. Additionally, he has developed CRISPR editing techniques to incorporate nucleic acid landing pads into the genomes of live cells. This innovative approach allows for the multiplex delivery of 'landing pad' edits, facilitating the insertion of large DNA sequences into the genomes of living cellular populations.

Career Highlights

Daniel currently works at Inscripta, Inc., a company that specializes in innovative genome engineering solutions. His career is marked by a dedication to advancing the field of synthetic biology and genetic research, emphasizing the importance of practical applications for his inventions.

Collaborations

Throughout his career, Daniel has collaborated with notable colleagues, including Richard Fox and Eric Abbate. These partnerships underscore the collaborative spirit prevalent in the research and development environment at Inscripta, Inc., fostering groundbreaking ideas and inventions.

Conclusion

Daniel Held exemplifies the spirit of innovation in biotechnology. His contributions not only reflect his expertise as an inventor but also highlight the transformative potential of his inventions for industries reliant on genetic engineering and production enhancement. With his ongoing work, the future of synthetic biology remains bright, driven by pioneers like him.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…